Diagnostic Laboratory Technologies for the Fetus and Neonate with Isoimmunization

Seminars in Perinatology

Volumn 35, Issue 3, 2011, Pages 148-154

  Geaghan, Sharon Markham ^a,b  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ABO incompatibility; Hemolytic disease of the newborn; Kleihauer betke; Neonatal alloimmunization; RhD alloimmunization

Indexed keywords

BILIRUBIN; MATERNAL ANTIBODY;

ALLOIMMUNIZATION; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD SMEAR; CLINICAL CHEMISTRY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOPPLER FLOWMETRY; FETAL HEMORRHAGE; FETOPLACENTAL UNIT; FETUS; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; NEWBORN; NEWBORN ASSESSMENT; OUTCOME ASSESSMENT; PLACENTAL TRANSFER; PRIORITY JOURNAL; REVIEW; RHESUS INCOMPATIBILITY; RHESUS ISOIMMUNIZATION;

ABO BLOOD-GROUP SYSTEM; CLINICAL LABORATORY TECHNIQUES; FEMALE; FETUS; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM;

EID: 79957950788     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2011.02.009     Document Type: Review

References (35)

1. Kennedy M.S. Perinatal issues in transfusion practice. Technical Manual 2008, 625-637. AABB, Bethesda, MD. (ed 16). J.D. Roback, M.R. Combs (Eds.).
2. Katz M.A., Kanto W.P., Korotkein J.H. Recurrence rate of ABO hemolytic disease of the newborn. Obstet Gynecol 1982, 59:611.
3. Levine P., Stetson R.E. Unusual cases of intragroup agglutination. JAMA 1939, 113:126-127.
4. Hadley A.G. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn. Transpl Immunol 2002, 10:191-198.
5. Choavarantana R., Uer-Areewong S., Makanantakocol S. Fetomaternal transfusion in normal pregnancy and during delivery. J Med Assoc Thai 1997, 80:96.
6. Lack of transmission of human immunodeficiency virus through Rho (D) immune globulin (human). Morb Mortal Wkly Rep 1987, 36:728. Centers for Disease Control.
7. Beischer N.A. ABO incompatibility: When is antenatal testing indicated?. Aust N Z J Obstet Gynaecol 1997, 37:315.
8. Moncharmont P., Juron-Dupraz F., Vignal M., et al. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: Thirty years of experience. Arch Gynecol Obstet 1991, 248:175-180.
9. Judd W.J. Guidelines for Prenatal and Perinatal Immunohematology 2005, AABB, Bethesda, MD.
10. Standards for Blood Banks and Transfusion Services 2008, 55-56. AABB, Bethesda, MD. (ed 25). T.H. Price (Ed.).
11. Sebing E.S., Polesky H.F. Comparison of fetomaternal hemorrhage detection methods and Rh immune globulin usage. Am J Clin Pathol 1979, 72(2 suppl):358-362.
12. Chen J.C., Davis B.H., Wood B., et al. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection. Cytometry 2002, 50:285-290.
13. Heddle N.M., Klama L., Frasetto R., et al. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion 1993, 23:217-220.
14. Vaughan J.I., Manning M., Warwick R.M., et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998, 338:798-803.
15. Bevis D.C.A. Composition of liquor amnii in haemolytic disease of the newborn. J Obstet Gynaecol Br Emp 1953, 60:244-251.
16. Liley A.W. Liquor amnii analysis in the management of pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol 1961, 82:1359-1370.
17. Queenan J.T., Tomai T.P., Serdar H.U., et al. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: A proposal for clinical management. Am J Obstet Gynecol 1993, 168:1370-1376.
18. Mari G., Hanif F. Fetal Doppler: Umbilical artery, middle cerebral artery, and venous system. Semin Perinatol 2008, 32:253-257.
19. Oepkes D., Seaward P.G., Vandenbussche F.P., et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006, 355:156-164.
20. Zimmerman R., Carpenter R.J., Durig P., et al. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: A prospective multicentre trial with intention-to-treat. Br J Obstet Gynaecol 2002, 109:746-752.
21. Moise K.J. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol 2008, 198:e1-e4.
22. Mari G. Noninvasivediagnosis by Doppler ultrasonography of fetal anemia due to fetal anemia due to maternal red-cell alloimmunization. N Engl J Med 2000, 342:9-14.
23. Singhal P.K., Singh M., Paul V.K., et al. Spectrum of neonatal hyperbilirubinemia: An analysis of 454 cases. Indian Pediatr 1992, 29:319-325.
24. Geaghan S.M. Hematologic values and appearances in the healthy fetus, neonate and child. Clinics in Laboratory Medicine: Diagnostic Pediatric Hematology 1999, Vol. 19. WB Saunders, Philadelphia, PA. S.M. Geaghan (Ed.).
25. McPherson R.A., Pincus M.R. Henry's Clinical Diagnosis and Management by Laboratory Methods 2007, Saunders Elsevier, Philadelphia, PA. (ed 21).
26. Kanakoudi F., Drossou V., Tzimouli V., et al. Serum concentrations of 10 acute-phase proteins in healthy term and preterm infants from birth to age 6 months. Clin Chem 1995, 41:605-608.
27. Vengelen-Tyler V. The serological investigation of hemolytic disease of the newborn caused by antibodies other than anti-D. Hemolytic Disease of the Newborn 1984, 145-172. AABB, Arlington, VA. G. Garratty (Ed.).
28. Management of hyperbilirubinemia in the newborn 35 or more weeks gestation. Clinical practice guideline. Pediatrics 2004, 114:297-316. American Academy of Pediatrics: Subcommittee on hyperbilirubinemia.
29. Herschel M., Karrison T., Wen M., et al. Isoimmunization is unlikely to be cause of hemolysis in ABO-incompatible but direct antiglobulin test-negative neonates. Pediatrics 2002, 110:127-130.
30. Kaplan M., Hammerman C., Renbaum P., et al. Gilbert's syndrome and hyperbilirubinemia in ABO-incompatible neonates. Lancet 2000, 356:652-653.
31. Lynen R., Neuhaus R., Schwarz D.W.M., et al. Flow cytometric analyses of the subclasses of red cell IgG antibodies. Vox Sang 1995, 69:126-130.
32. Mundy C.A. Intravenous immunoglobulin in the management of hemolytic disease of the newborn. Neonat Netw 2005, 24:17-24.
33. Pollock J.M., Bowman J.M. Placental transfer of Rh antibody (anti-D IgG) during pregnancy. Vox Sang 1982, 43:327-334.
34. Avent N.D. RHD genotyping from maternal plasma: Guidelines and technical challenges. Methods Mol Biol 2008, 444:185-201.
35. Hall A.M., Cairns L.S., Altmann D.M., et al. Immune responses and tolerance to the RhD blood group proteins in HLA-transgenic mice. Blood 2005, 105:2175-2179.